Soluble CD40 as a modulator of CD40 pathway

Immunology Letters

Volumn 147, Issue 1-2, 2012, Pages 85-86

  Esposito, Pasquale ^a   Rampino, Teresa ^a   Dal Canton, Antonio ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

CD40; Costimulatory molecules; Multiple myeloma; Soluble CD40

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY;

ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; B LYMPHOCYTE ACTIVATION; HUMAN; LETTER; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD40; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG RESISTANCE, NEOPLASM; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; VINCRISTINE;

EID: 84865376354     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.06.003     Document Type: Letter

References (16)

1. Lee S.W., Cho H.Y., Na G., Yoo M.R., Seo S.K., Hur D.Y., et al. CD40 stimulation induces vincristine resistance via AKT activation and MRP1 expression in a human multiple myeloma cell line. Immunol Lett 2012, 144:41-48.
2. van Kooten C. Immune regulation by CD40-CD40-l interactions - 2; Y2K update. Front Biosci 2000, 5:D880-D893.
3. Grammer A.C., Slota R., Fischer R., Gur H., Girschick H., Yarboro C., et al. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154- CD40 interactions. J Clin Invest 2003, 112:1506-1520.
4. Aoyagi T., Yamashita K., Suzuki T., Uno M., Goto R., Taniguchi M., et al. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy. Am J Transplant 2009, 9:1732-1741.
5. Xu W., Li Y., Wang X., Wang C., Zhao W., Wu J. Anti-tumor activity of gene transfer of the membrane-stable CD40L mutant into lung cancer cells. Int J Oncol 2010, 37:935-941.
6. Göçmen A.Y., Burgucu D., Gümüşlü S. Effect of resveratrol on platelet activation in hypercholesterolemic rats: CD40-CD40L system as a potential target. Appl Physiol Nutr Metab 2011, 36:323-330.
7. Boumpas D.T., Furie R., Manzi S., Illei G.G., Wallace D.J., Balow J.E., et al. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum 2003, 48:719-727.
8. Pluvinet R., Pétriz J., Torras J., Herrero-Fresneda I., Cruzado J.M., Grinyó J.M., et al. RNAi-mediated silencing of CD40 prevents leukocyte adhesion on CD154-activated endothelial cells. Blood 2004, 104:3642-3646.
9. Geraldes P., Gagnon S., Hadjadj S., Merhi Y., Sirois M.G., Cloutier I., et al. Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ERa-mediated pathway. Cardiovasc. Res. 2006, 71:566-573.
10. Chakrabarti S., Vitseva O., Iyu D., Varghese S., Freedman J.E. The effect of dipyridamole on vascular cell-derived reactive oxygen species. J. Pharmacol. Exp. Ther. 2005, 315:494-500.
11. Tousoulis D., Antoniades C., Nikolopoulou A., Koniari K., Vasiliadou C., Marinou K., et al. Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes. Eur J Clin Invest 2007, 37:623-628.
12. van Kooten C., Gaillard C., Galizzi J.P., Hermann P., Fossiez F., Banchereau J., et al. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol 1994, 24:787-792.
13. Contin C., Pitard V., Delmas Y., Pelletier N., Defrance T., Moreau J.F., et al. Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients. Immunology 2003, 110:131-140.
14. Esposito P., Gabanti E., Bianzina S., Rampino T., Dal Canton A. CD40/SCD40 imbalance in hemodialysis patients. Clin Biochem 2011, 44:268-269.
15. Contin C., Lacraz A., de Preócigout V. Potential role of the soluble form of CD40 in deficient immunological function of dialysis patients: new findings of its amelioration using polymethylmethacrylate (PMMA) membrane. NDT Plus 2010, 3:i20-i27.
16. Hock B.D., McKenzie J.L., Patton N.W., Drayson M., Taylor K., Wakeman C., et al. Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies. Cancer 2006, 106:2148-2157.